Julphar on track for 2020 goal

Julphar, the largest generic pharmaceutical manufacturer in Middle East and North Africa, announced sales revenue of Dh639 million in the first semester of 2017, with net profit at Dh64 million.

Sheikh Faisal bin Saqr Al Qasimi, Chairman of Julphar, said: “Julphar is now moving forward towards achieving its objectives for 2020 to stay at the top of the regional market... the company has kept its leading position in the UAE by achieving a robust double digit growth in the second quarter of 2017.”